Program

April 15, 2018

09:00 to 16:00 Workshop FD-1
An Introduction to Health Technology Assessment
Introductory. Will be of particular interest to patients, students, and people new to health technology assessment (HTA).
09:00 to 12:00 Workshop AM-1
Clearer Communication and Plain-Language Writing: Making Health Research Make Sense
Intermediate. Will be of interest to all audiences.
09:00 to 12:00 Workshop AM-2
Oncology’s Next Top Model: Survival Extrapolation Methods Under the Spotlight
Intermediate. Will be of particular interest to HTA producers.
09:00 to 12:00 Workshop AM-3
Rapid Reviews: From Policy Question to Research and Decision-Making
Intermediate. Will be of particular interest to decision-makers, HTA producers, and those involved in dissemination and implementation efforts.
09:00 to 12:00 Workshop AM-4
Developing, Implementing, and Evaluating Roles for Community Pharmacists in Mental Illness and Addictions Care
Intermediate. Will be of particular interest to patients, policy-makers, and health care professionals.
09:00 to 12:00 Workshop AM-5
Is Your Intervention Cost-Effective in the Real World? The Role of Economic Evaluation Using Person-Level Data
Intermediate. Will be of particular interest to researchers, HTA producers, and health care professionals.
09:00 to 12:00 Workshop AM-6
The Role of and Developments in Database Search Filters in Health Technology Assessment
Introductory. Will be of particular interest to information specialists, health librarians, and others interested in retrieving evidence-informed health information.
09:00 to 12:00 Workshop AM-7
CANCELLED - How Can Policy-Makers and Clinicians Trust the Results of a Network Meta-Analysis? A Workshop on How to Apply the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Tool
Intermediate. Will be of particular interest to policy-makers and health care professionals.
12:00 to 14:00
Roundtable: Insights and Opportunities for Improving Mental Health in Canada

13:00 to 16:00 Workshop PM-1
Introduction to the Design of Markov Models for Economic Evaluation
Intermediate. Will be of particular interest to decision-makers, HTA producers, and researchers.
13:00 to 16:00 Workshop PM-2
Making Tough Decisions: An Interactive Deliberative Exercise
Introductory. Will be of particular interest to patients, students, and those who are new to HTA.
13:00 to 16:00 Workshop PM-3
Fast-Forward, Pause, Rewind: Applied Critical Appraisal in the Drug Product Life Cycle
Intermediate. Will be of particular interest to health care professionals and policy-makers.
13:00 to 16:00 Workshop PM-4
Using the Media to Drive Evidence-Based Change
Introductory. Will be of interest to all audiences.
13:00 to 16:00 Workshop PM-5
Accelerating Innovation for Enhancing Health Care Through Effective Health Technology Management
Introductory. Will be of particular interest to policy-makers.
13:00 to 16:00 Workshop PM-6
Applying Different Study Designs for Comparative Effectiveness Research in Health Technology Assessment
Intermediate. Will be of particular interest to researchers and HTA producers.
13:00 to 16:00 Workshop PM-7
A Users’ Guide to Qualitative-Evidence Synthesis
Introductory. Will be of particular interest to policy-makers.
13:00 to 16:00 Workshop PM-8
Living Systematic Reviews
Intermediate. Will be of particular interest to HTA producers, systematic review authors, and coordinators.
16:15 to 17:00
Patient Group Meet and Greet

16:15 to 17:00
Student Meet and Greet

17:00 to 19:00
Welcome Reception and Scientific Poster Exhibition

April 16, 2018

09:00 to 09:30
Official Opening

09:30 to 10:45 Opening Plenary
Health Priorities in a Changing Health Care Landscape

11:15 to 12:30 Concurrent Session A1 — Panel Discussion
Health Technology Management and Value-Based Procurement in Medical Devices: A Convergence of Two Worlds?

11:15 to 12:30 Concurrent Session A2 — Panel Discussion
An Overview of a Provincial “Appropriateness of Care” Initiative: A Provincial Collaborative Supporting Appropriate, Affordable, and Accessible Care

11:15 to 12:30 Concurrent Session A3 — Panel Discussion
Real World Data and Evidence for Decision-Making to Improve Access to and Appropriateness and Affordability of Innovative Medicines for Canadians

11:15 to 12:30 Concurrent Session A4 — Panel Discussion
Deprescribing by Policy

11:15 to 12:30 Concurrent Session A5 — Panel Discussion
Patient Assistance Programs For Patient Access or Market Access?

11:15 to 12:30 Concurrent Session A6 — Panel Discussion
Placing Data Within a Knowledge-Based Healthcare and Social Services System: A Growing Experience for INESSS

11:15 to 12:30 Concurrent Session A7 — Panel Discussion
CANCELLED - Enhancing the Management of Pharmaceuticals in Canada

13:30 to 14:45 Concurrent Session B1 — Oral Presentations
Hot Topics

13:30 to 14:45 Concurrent Session B2 — Oral Presentations
Beyond Traditional Health Technology Assessment

13:30 to 14:45 Concurrent Session B3 — Oral Presentations
Medical Devices — Decision-making

13:30 to 14:45 Concurrent Session B4 — Oral Presentations
Drug Expenditures

13:30 to 14:45 Concurrent Session B5 — Oral Presentations
Health Technology Assessment Methods

13:30 to 14:45 Concurrent Session B6 — Oral Presentations
Knowledge Mobilization and Implementation Support

13:30 to 14:45 Concurrent Session B7 — Oral Presentations
Patient and Public Engagement

13:30 to 14:45 Concurrent Session B8 — Oral Presentations
Health Economics Methods

15:15 to 16:30 Concurrent Session C1 — Panel Discussion
The Growing Cost of Oncology Drugs: Is It Sustainable?

15:15 to 16:30 Concurrent Session C2 — Panel Discussion
HTA for Indigenous Decision-Makers: What Is Needed? What Is Appropriate?

15:15 to 16:30 Concurrent Session C3 — Panel Discussion
Essential Medicines in Canada: What is Essential and How Accessible Is It?

15:15 to 16:30 Concurrent Session C4 — Panel Discussion
What Is It to “Think Qualitatively” Within Health Technology Assessments?

15:15 to 16:30 Concurrent Session C5 — Panel Discussion
Patients, Patient Groups, and Patient Engagement: Blockbuster or Boondoggle?

15:15 to 16:30 Concurrent Session C6 — Panel Discussion
Evidence-to-Action: Canadian Medical Imaging Inventory

15:15 to 16:30 Concurrent Session C7 — Panel Discussion
Using Health Care Administrative and Other Real-World Data Sources for Decision-Making — What Role for Health Technology Assessment?

15:15 to 16:30 Concurrent Session C8 — Panel Discussion
Collaborative HTA: The Whole is Greater than the Sum of its Parts

17:30 to 21:00
Social Event: Dinner at Pier 21

April 17, 2018

07:30 to 08:30 Breakfast Session 1
Medical Devices: Overview of Epidemiologic and Qualitative Research on Recalls, Decision-Making, and Adverse-Event Reporting in Canada

07:30 to 08:30 Breakfast Session 2
Wax On, Wax Off. Wax On, Wax Off: A Rapid Mentorship Session on How to Succeed in Health Technology Assessment

07:30 to 08:30 Breakfast Session 3
National Pain Strategy Development — Rationale and Process: Exemplars From Other Fields

07:30 to 08:30 Breakfast Session 4
What Medicines Are Essential in Canada?

07:30 to 08:30 Breakfast Session 5
Medical Cannabis: Equal Access for All?

07:30 to 08:30 Breakfast Session 6
An EXCITE-ing Process for Evaluating Medical Devices: The Case of Continuous Glucose Monitoring in Type 1 Diabetes

07:30 to 08:30 Breakfast Session 7
Dalhousie Academic Detailing Service: From Vision to Visit

07:30 to 08:30 Breakfast Session 8
Proposed Changes to Canada’s PMPRB Budget Impact Analysis Guidelines for New Drug Submissions to Public and Private Payers

08:45 to 10:00 Plenary Session
Beyond Health Technology Assessment: What Does Health Technology Management Mean for Patients and the Health System?

10:30 to 11:45 Concurrent Session D1 — Oral Presentations
Real-world Evidence

10:30 to 11:45 Concurrent Session D2 — Oral Presentations
Precision Medicine

10:30 to 11:45 Concurrent Session D3 — Oral Presentations
Economic Evaluations — Medical Devices

10:30 to 11:45 Concurrent Session D4 — Oral Presentations
Health Economics Methods

10:30 to 11:45 Concurrent Session D5 — Oral Presentations
Opioids

10:30 to 11:45 Concurrent Session D6 — Oral Presentations
The Patient’s Experience

10:30 to 11:45 Concurrent Session D7 — Oral Presentations
Qualitative Evidence

13:15 to 14:30 Concurrent Session E1 — Panel Discussion
Health Technology Assessment: Examining Conventional, Complementary, and Traditional Approaches to Health Care

13:15 to 14:30 Concurrent Session E2 — Panel Discussion
Can Outcomes-Based Agreements Support Appropriate, Affordable, and Accessible Health Care?

13:15 to 14:30 Concurrent Session E3 — Panel Discussion
Beyond Buprenorphine and Methadone: The Role of Emerging Drugs in the Treatment of Opioid Addiction

13:15 to 14:30 Concurrent Session E4 — Panel Discussion
Laying the Foundation for a New Health Canada and HTA Alignment: Perspectives on Evidence and Value Assessments From the Health Canada–pCODR (CADTH pan-Canadian Oncology Drug Review) Pilot Project

13:15 to 14:30 Concurrent Session E5 — Panel Discussion
As Canadians Consider Adopting National Universal Pharmacare, Will Rare-Disease Therapies Remain Orphans?

13:15 to 14:30 Concurrent Session E6 — Panel Discussion
Antimicrobial-Resistance Drugs: From Drug Discovery to Access — Is Canada Prepared for Their Entry?

13:15 to 14:30 Concurrent Session E7 — Panel Discussion
CANCELLED - The Role of the Patient in Health Technology Assessment and Health Technology Management for Precision-Medicine Treatment of Lethal and Other Serious Diseases: A National Perspective

13:15 to 14:30 Concurrent Session E8 — Panel Discussion
Gene Therapy: Where Is It Headed and How Do We Prepare for It?

15:00 to 16:15 Closing Plenary
Appropriate, Affordable, and Accessible Drug Therapy: Can We Have It All?

16:15 to 16:30
Official Closing